Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

NCT00389428 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Neoplasms

Interventions

DRUG: CPX-351 (Cytarabine:Daunorubicin) Liposome Injection

Sponsor

Jazz Pharmaceuticals